Application 219404
- Type
- ANDA
- Sponsor
- LUPIN LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | OXCARBAZEPINE EXTENDED RELEASE TABLETS | OXCARBAZEPINE | TABLET;EXTENDED RELEASE | 300MG | No | No |
| 003 | OXCARBAZEPINE EXTENDED RELEASE TABLETS | OXCARBAZEPINE | TABLET;EXTENDED RELEASE | 600MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | Golden State Medical Supply, Inc. | b9db5c45-8b51-449b-b4af-1a235c08f189 | 2025-12-11 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Glenmark Pharmaceuticals Inc., USA | 1c713b59-a628-42e6-b166-ae71c3913284 | 2025-12-03 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Ajanta Pharma USA Inc. | d947e9b1-2a15-4048-bb4e-fe56b6851848 | 2025-11-30 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bionpharma Inc. | ec033897-21b4-4d08-83de-042783e89251 | 2025-11-28 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | a1b6a698-f7d9-4adb-9e38-b63e7a85e2b3 | 2025-10-24 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 1176d5f5-3447-4925-aed8-1a1cb4b5989d | 2025-10-13 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Amneal Pharmaceuticals LLC | 2515391e-3a88-4226-92e5-f641c8409fe5 | 2025-10-01 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Coupler LLC | 3f15c889-4386-850b-e063-6294a90a8dbf | 2025-09-18 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Preferred Pharmaceuticals Inc. | e156339c-f79e-4a20-b9da-f50bea948213 | 2025-09-05 | Warnings, Adverse reactions | OXCARBAZEPINE |
| oxcarbazepine | OXCARBAZEPINE | Macleods Pharmaceuticals Limited | 962098cc-2d84-4723-a296-b110f1fd659e | 2025-08-29 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Ascend Laboratories, LLC | 3f36f519-c30c-4929-afa0-9844dc531e3f | 2025-07-22 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Marlex Pharmaceuticals, Inc | d3684d55-0564-4849-bdf6-b91f22a3e28c | 2025-06-25 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Ingenus Pharmaceuticals, LLC | 70798ca9-0eda-49c0-8a7c-b775b6ae3d69 | 2025-04-12 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Proficient Rx LP | 433d9d03-a36e-42c6-8e4d-f333ed60e45a | 2025-03-01 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | NorthStar RxLLC | 1746d95f-c529-45ba-a520-0c135e8edda8 | 2025-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | DirectRx | dbea45c2-e166-b557-e053-2995a90a7643 | 2025-01-22 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 23137a89-cbd0-4a5f-8220-f26b7ba54330 | 2025-01-21 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | AvPAK | fd8da0e9-d69b-7587-e053-6294a90a33c0 | 2025-01-09 | Warnings, Adverse reactions | OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | EPIC PHARMA, LLC | 62ab716b-f05f-454d-95b3-1a382cdf7226 | 2025-01-07 | Warnings, Adverse reactions | OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Novadoz Pharmaceuticals LLC | 03bec567-a9c3-4d82-9679-fec5324d0df6 | 2024-11-18 | Warnings, Adverse reactions | OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.